Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Medical University of Gdansk · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
leukemialymphomavenous-thromboembolism
lymphoma, leukemia, multiple myeloma (mm), lymphoma, large b-cell, diffuse (dlbcl), lymphoma, venous thromboembolic disease, vte (venous thromboembolism), pe - pulmonary embolism, hematologic malignacies, apixaban, rivaroxaban, low-molecular-weight heparin, venous thromboembolism, cancer-associated thrombosis
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 802013
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.